SOM230: A new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

Endocrinology

Volumn 143, Issue 10, 2002, Pages 4123-4130

  Weckbecker, Gisbert ^a   Briner, Ulrich ^a   Lewis, Ian ^a   Bruns, Christian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEXAPEPTIDE; OCTREOTIDE; PASIREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOG; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG STRUCTURE; HORMONE INHIBITION; HORMONE RECEPTOR INTERACTION; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; DOGS; EATING; GROWTH HORMONE; HORMONES; INSULIN-LIKE GROWTH FACTOR I; MACACA FASCICULARIS; MACACA MULATTA; OCTREOTIDE; RATS; SOMATOSTATIN; TIME FACTORS;

EID: 0036773070     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220219     Document Type: Article

References (31)

1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R 1973 Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
2. Reichlin S 1983 Somatostatin. N Engl J Med 309:1556-1563
3. Lichtenauer-Kaligis EGR, Van Hagen PM, Lamberts SWJ, Hofland LJ 2000 Somatostatin receptor subtypes in human immune cells. Eur J Endocrinol 143:S21-S25
4. Patel YC 1997 Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 20:348-367
5. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
6. Meyerhof W 1998 The elucidation of somatostatin receptor functions: A current view. Rev Physiol Biochem Pharmacol 133:55-105
7. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J 1982 SMS 201-995: a very potent and selective octapeptide analog of SRIF with prolonged action. Life Sci 31:1133-1140
8. Bruns C, Raulf F, Hoyer D, Schloos J, Luebbert H, Weckbecker G 1996 Binding properties of somatostatin receptor subtypes. Metab Clin Exp 44:17-20
9. Lamberts SW, van der Lely AJ, De Herder WW, Hofland LJ 1996 Octreotide. N Engl J Med 334:246-254
10. Hannon JP, Bruns C, Weckbecker G, Hoyer D, Somatostatin receptor gene family-subtype selectivity for ligand binding. In: Patel YC, ed. Somatostatin, in press
11. Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF 1995 Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients. J Clin Endocrinol Metab 80:2768-2775
12. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S 2000 Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 85:526-529
13. Bass RT, Buckwalter BL, Patel BP, Pausch MH, Price LA, Strnad J, Hadcock JR 1996 Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 50:709-715
14. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WWS, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM 1998 Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282:737-740
15. Ankersen M, Crider M, Liu S, Ho B, Andersen HS, Stidsen C 1998 Discovery of a novel non-peptide somatostatin agonist with sst4 selectivity. J Am Chem Soc 120:1368-1373
16. Coy DH, Taylor JE 1996 Receptor-specific somatostatin analogs: Correlations with biological activity. Metab Clin Exp 44:21-23
17. Coy DH, Taylor JE 1999 Development of somatostatin agonists with high affinity and specificity for the human and rat type 5 receptor subtype. Proc Am Pept Symp 15:559-560
18. Reubi JC, Schaer JC, Wenger S, Hoeger C, Erchegyi J, Waser B, Rivier J 2000 SST3-selective potent peptidic somatostatin receptor antagonists. Proc Natl Acad Sci USA 97:13973-13978
19. Savenu A, Gunz G, Dufour H, Caron P, Fina F, Quafic L, Culler MD, Moreau JP, Enalbert A, Jaquet P 2001 BIM-23244, a somatostatin receptor subtype 2-and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. J Clin Endocrinol Metab 86:140-145
20. Eigenmann JE, Patterson DF, Zapf J, Froesch ER 1984 Insulin-like growth factor I in the dog: A study in different dog breeds and in dogs with growth hormone elevation. Acta Endocrinol (Copenh) 105:294-301
21. Liapakis G, Hoeger C, Rivier J, Reisine T 1996 Development of a selective agonist at the somatostatin receptor subtype SSTR1. J Pharmacol Exp Ther 276:1089-1094
22. Baumbach WR, Carrick TA, Pausch MH, Bingham B, Carmignac D, Robinson ICAF, Houghten R, Eppler CM, Price LA, Zysk JR 1998 A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol Pharmacol 54:864-873
23. Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan Y, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett A 1998 Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA 95:10836-10841
24. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and 5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99:789-798
25. Shimon I, Yan X, Taylor JI, Weiss MH, Culler MD, Melmed S 1997 Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors J Clin Invest 100:2386-2392
26. Lanneau C, Bluet-Pajot MT, Zizzari P, Csaba Z, Dournaud P, Helboe L, Hoyer D, Pellegrini E, Tannenbaum GS, Epelbaum J, Gardette R 2000 Involvement of the sstl somatostatin receptor subtype in the intrahypothalamic neuronal network regulating growth hormone secretion: An in vitro and in vivo antisense study. Endocrinology 141:967-979
27. Gu ZF, Corleto VD, Mantey SA, Coy DH, Maton PN, Jensen RT 1995 Somatostatin receptor 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. Am J Physiol 268:G739-G748
28. Sharma K, Srikant CB 1998 Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 76:259-266
29. Weckbecker G, Stolz B, Susini C, Bruns C 1999 Antiproliferative somatostatin analogues with potential in oncology. In: Lamberts S, ed. Octreotide, the next decade. Bristol, UK: BioScientifica; 339-352
30. Ferjoux G, Bousquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L, Susini C 2000 Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol (Paris) 94:205-210
31. Sjögren K, Liu J-L, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Törnell J, Isaksson OGP, Jansson J-O, Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092